Medality Medical LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial

Press/Media: Press / Media

PeriodFeb 14 2019 → Feb 15 2019

Media coverage

3

Media coverage

  • TitleMedality Medical LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletAsian Hospital & Healthcare Management
    CountryIndia
    Date2/15/19
    PersonsRichard M Peterson, Ralph A Defronzo
  • TitleMedality Medical LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletIndia Pharma News
    CountryIndia
    Date2/14/19
    PersonsRichard M Peterson, Ralph A Defronzo
  • TitleMedality Medical LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date2/14/19
    PersonsRichard M Peterson, Ralph A Defronzo